THIS SITE IS INTENDED FOR U.S. RESIDENTS ONLY

THIS SITE IS INTENDED
FOR U.S. RESIDENTS ONLY

FOR U.S. HEALTHCARE
PROFESSIONALS ONLY

FOR U.S. HEALTHCARE PROFESSIONALS ONLY

Patient Support and Resources

Ipsen Cares Patient Support Program Offerings

Visit www.ipsencares.com to learn more about support
for eligible TAZVERIK® patients

Patient Assistance Program (PAP)

Patient Assistance

Program (PAP)

Patients may be eligible to receive a limited supply of free medication if they are uninsured or underinsured (based on program eligibility criteria).

Bridge Supply Program

Bridge Supply Program

Helping existing commercial patients access medication should they experience change or delay in drug coverage.

Patient Assistance Program (PAP)

Patient Assistance

Program (PAP)

Patients may be eligible to receive a limited supply of free medication if they are uninsured or underinsured (based on program eligibility criteria).

Quick Start Program

Quick Start Program

New commercial patients may be eligible to receive a limited supply of free medication.

Quick Start Program

Quick Start Program

New commercial patients may be eligible to receive a limited supply of free medication.

Co-Pay Assistance

Co-Pay Assistance Program

Patients with commercial health insurance may be eligible to receive co-payment assistance from Ipsen to help reduce out-of-pocket costs for TAZVERIK.*

Bridge Supply Program

Bridge Supply Program

Helping existing commercial patients access medication should they experience change or delay in drug coverage.

Co-Pay Assistance

Co-Pay Assistance Program

Patients with commercial health insurance may be eligible to receive co-payment assistance from Ipsen to help reduce out-of-pocket costs for TAZVERIK.*

ipsencares

If you are interested in learning more about any of the support offerings mentioned, including eligibility requirements, visit ipsencares.com or contact Ipsen Cares at 1-866-435-5677, Monday through Friday, 8 AM - 8 PM ET.

Note: All support is subject to eligibility criteria and program terms and conditions found on ipsencares.com.

*Patient Eligibility & Terms and Conditions: Patients are not eligible for copay assistance through IPSEN CARES® if they are enrolled in any state or federally funded programs for which drug prescriptions or coverage could be paid in part or in full, including, but not limited to, Medicare Part B, Medicare Part D, Medicaid, Medigap, VA, DoD, or TRICARE (collectively, “Government Programs”), or where prohibited by law. Patients receiving assistance through another assistance program or foundation, free trial, or other similar offer or program, are not eligible for the copay assistance program during the current enrollment year.

Educational materials and resources

While your healthcare team can provide support throughout your follicular lymphoma (FL) journey, there are other organizations and communities that may be able to help.

CancerCare

cancercare.org

1-800‑813‑HOPE (4673)

The Leukemia & Lymphoma Society (LLS)

LLS.org

1-800-955-4572

Lymphoma Research Foundation (LRF)

lymphoma.org

1-800-500-9976

Downloads

thumb-taz-patient-brochure

FL Patient Brochure

Find helpful information about follicular lymphoma and treatment.

DOWNLOAD
discussion-guide

Doctor Discussion Guide

You can use this as a guide to help you prepare for your appointments and choose questions you may want to ask your doctor.

DOWNLOAD
thumb-resource-guide1

Ipsen Cares Patient Flashcard

Find more information about Ipsen Cares support for eligible TAZVERIK patients.

DOWNLOAD

Learn more about recommended dosing and how to take TAZVERIK.

DOSING & ADMINISTRATION

IMPORTANT SAFETY INFORMATION AND INDICATIONS

What is the most important information I should know about TAZVERIK?

TAZVERIK can cause serious side effects, including:

  • Risk of new cancers. An increase in new (second) cancers has happened in people who were treated with TAZVERIK. Talk with your healthcare provider about your risk of developing new cancers. Your healthcare provider will monitor you for new cancers after your treatment with TAZVERIK. Tell your healthcare provider if you are more tired than usual, or have easy bruising, fever, bone pain, or paleness.

Before taking TAZVERIK, tell your healthcare provider about all of your medical conditions, including if you:

  • Are pregnant or plan to become pregnant. TAZVERIK can harm your unborn baby. Your healthcare provider will give you a pregnancy test before you start treatment with TAZVERIK. Tell your healthcare provider right away if you become pregnant or think you may be pregnant.
    • Females who are able to become pregnant should use effective non-hormonal birth control (such as condoms) during treatment and for 6 months after the final dose of TAZVERIK. Birth control pills (oral contraceptives) and other hormonal forms of birth control may not be effective if used during treatment with TAZVERIK. Talk to your healthcare provider about birth control options that are right for you.
    • Males with female partners who are able to become pregnant should use effective birth control during treatment and for 3 months after the final dose of TAZVERIK.
  • Are breastfeeding or plan to breastfeed. It is not known if TAZVERIK passes into your breast milk. Do not breastfeed during treatment and for 1 week after the final dose of TAZVERIK.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. TAZVERIK may affect the way other medicines work and other medicines may affect how TAZVERIK works.

What should I avoid while taking TAZVERIK?

  • Avoid eating grapefruit or drinking grapefruit juice during treatment with TAZVERIK.
  • Avoid taking St. John’s wort during treatment with TAZVERIK.

Talk to your healthcare provider before starting any new medications or supplements.

What are the possible side effects of TAZVERIK?

The most common side effects of TAZVERIK in people with follicular lymphoma include:

  • Tiredness
  • Cold-like symptoms (upper respiratory infection)
  • Bone and muscle pain
  • Nausea
  • Stomach (abdominal) pain

These are not all the possible side effects of TAZVERIK.

Call your doctor for medical advice about side effects. You may report side effects to Ipsen Biopharmaceuticals, Inc. at 1-855-463-5127 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

INDICATIONS

What is TAZVERIK?

TAZVERIK is a prescription medicine used to treat:

  • Adults with follicular lymphoma when the disease has come back or did not respond to treatment, whose tumors have an abnormal EZH2 gene, and who have been treated with at least two prior medicines. Your healthcare provider will perform a test to make sure TAZVERIK is right for you.
  • Adults with follicular lymphoma when the disease has come back or did not respond to treatment, who have no other satisfactory treatment options.

The approval of TAZVERIK in these patients is based on a study that measured the percentage of patients whose tumor shrank or disappeared after treatment and how long that response lasted. TAZVERIK is still being studied to confirm these benefits.

It is not known if TAZVERIK is safe and effective in children less than 16 years of age.

Please see full Prescribing Information, including Medication Guide.

Ipsen logo

TAZVERIK is a registered trademark of Epizyme, Inc, an Ipsen company.
IPSEN CARES is a registered trademark of Ipsen S.A.
All other trademarks and registered trademarks are property of their respective owners.

TAZVERIK is a registered trademark of Epizyme, Inc, an Ipsen company. IPSEN CARES is a registered trademark of Ipsen S.A. All other trademarks and registered trademarks are property of their respective owners.

TAZVERIK is a registered trademark of Epizyme, Inc, an Ipsen company.

IPSEN CARES is a registered trademark of Ipsen S.A.

All other trademarks and registered trademarks are property of their respective owners.

©2024 Ipsen Biopharmaceuticals, Inc. All rights reserved. TAZ-US-000454 01/24

©2024 Ipsen Biopharmaceuticals, Inc. All rights reserved. TAZ-US-000454 01/24